Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q35025403
Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaSorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.Hepatitis C virus-mediated angiogenesis: molecular mechanisms and therapeutic strategies.Comparison of treatment safety and patient survival in elderly versus nonelderly patients with advanced hepatocellular carcinoma receiving sorafenib combined with transarterial chemoembolization: a propensity score matching studyDecrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spreadeNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study.Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation.Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score.Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review.Sorafenib Monotherapy Versus Sorafenib Combined with Regional Therapies for Hepatocellular Carcinoma Patients with Pulmonary Oligometastases: A Propensity Score-matched Analysis.Surgical Resection Is Better than Transarterial Chemoembolization for Hepatocellular Carcinoma Beyond Milan Criteria Independent of Performance Status
P2860

Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q35025403
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@ast
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@en
type
label
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@ast
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@en
prefLabel
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@ast
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Efficacy of sorafenib monother ...... nced hepatocellular carcinoma.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0077240
P407
P433
P478
P50
P577
P5875
P698
P932